Trial · NCT01374906
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | 10 mg Pasireotide LAR Dose | 74 | |
| Overall Study | STARTED | 30 mg Pasireotide LAR Dose | 76 | |
| Overall Study | DC Dur Core Phs at/Prior to Data Cutoff | 10 mg Pasireotide LAR Dose | 24 | |
| Overall Study | DC Dur Core Phs at/Prior to Data Cutoff | 30 mg Pasireotide LAR Dose | 22 | |
| Overall Study | Completed Core Phase | 10 mg Pasireotide LAR Dose | 50 | |
| Overall Study | Completed Core Phase | 30 mg Pasireotide LAR Dose | 54 | |
| Overall Study | Completed Core/Did Not Enter Ext. Phase | 10 mg Pasireotide LAR Dose | 10 | |
| Overall Study | Completed Core/Did Not Enter Ext. Phase | 30 mg Pasireotide LAR Dose | 13 | |
| Overall Study | Completed Core Phase/Entered Ext. Phase | 10 mg Pasireotide LAR Dose | 40 | |
| Overall Study | Completed Core Phase/Entered Ext. Phase | 30 mg Pasireotide LAR Dose | 41 | |
| Overall Study | DC Dur Ext Phs at/Prior to Data Cutoff | 10 mg Pasireotide LAR Dose | 16 | |
| Overall Study | DC Dur Ext Phs at/Prior to Data Cutoff | 30 mg Pasireotide LAR Dose | 26 | |
| Overall Study | Completed Extension Phase | 10 mg Pasireotide LAR Dose | 24 | |
| Overall Study | Completed Extension Phase | 30 mg Pasireotide LAR Dose | 15 | |
| Overall Study | COMPLETED | 10 mg Pasireotide LAR Dose | 34 | |
| Overall Study | COMPLETED | 30 mg Pasireotide LAR Dose | 28 | |
| Overall Study | NOT COMPLETED | 10 mg Pasireotide LAR Dose | 40 | |
| Overall Study | NOT COMPLETED | 30 mg Pasireotide LAR Dose | 48 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01374906/flow